Victor Carrion, MD

home / authors / victor-carrion-md

Victor Carrion, MD, director of the Stanford Early Life Stress Research Program and professor of child and adolescent psychiatry at Stanford University.

Articles

Victor Carrion, MD

Understanding childhood trauma, with Victor Carrion, MD

Victor Carrion, MD
May 29th 2025

Victor Carrion, MD, explains how providers can recognize the signs of accumulated stress in children and support recovery through education and connection.

Supporting mental health in pediatric primary care with Victor Carrion, MD

Supporting mental health in pediatric primary care with Victor Carrion, MD

Victor Carrion, MD
May 21st 2025

Victor Carrion, MD, emphasizes how pediatricians can monitor and support mental health in youth while navigating limited access to specialized care.

Latest Updated Articles

Published: March 21st 2023 | Updated: November 20th 2024
Guidelines for PUZZLER, Contemporary Pediatrics
CDC: Healthy children can receive COVID-19 vaccine via "shared clinical decision-making" | Image Credit: © ricka_kinamoto - © ricka_kinamoto - stock.adobe.com.
Published: June 2nd 2025 | Updated: June 12th 2025
CDC: Healthy children can receive COVID-19 vaccine via 'shared clinical decision-making'
Diagnose this infant with an asymptomatic pearl-like nodule on the heel
Published: June 3rd 2025 | Updated: June 12th 2025
Diagnose this infant with an asymptomatic pearl-like nodule on the heel
Diagnose this 18-day-old female with apnea, cyanosis, decreased feeding concerns
Published: May 5th 2025 | Updated: June 12th 2025
Diagnose this 18-day-old female with apnea, cyanosis, decreased feeding concerns
Poll: What's the diagnosis of this linear eruption on the leg of a 9-year-old girl? | Image credit: Author provided
Published: March 20th 2025 | Updated: June 12th 2025
Poll: What's the diagnosis of this linear eruption on the leg of a 9-year-old girl?
Nirsevimab demonstrates sustained efficacy in reducing RSV hospitalizations through 6 months | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.
Published: May 29th 2025 | Updated: June 12th 2025
Nirsevimab demonstrates sustained efficacy in reducing RSV hospitalizations through 6 months
© 2025 MJH Life Sciences

All rights reserved.